IMBDx (아이엠비디엑스) Company Profile: Funding, Investors & Partnerships

IMBDx (아이엠비디엑스)

IMB Dx is a liquid biopsy company which connects physicians and their patients to the latest cancer diagnostics approaches, making precision medicine a reality. The AlphaLiquid®Test enables treatment recommendation, recurrence monitoring and early diagnosis of cancer.IMB Dx is a liquid biopsy company which connects physicians and their patients to the latest cancer Show More

Alpha Score

67.4

Total Funding$ 20.77 M